. Cerebrospinal Aβ11-x and 17-x levels as indicators of mild cognitive impairment and patients' stratification in Alzheimer's disease. Transl Psychiatry. 2013 Jul 16;3:e281. PubMed.

AlzBiomarker Database

Meta-Analysis

Curated Study Data

Biomarker
(Source)
Cohort
(N)
Measurement
Mean ± SD
Method;
Assay Name;
Manufacturer
Diagnostic
Criteria
Aβ40
(CSF)
AD
(23)
133.69 ± 56.77
pg/mL
xMAP;
Other/Not Specified;
In-house
McKhann et al., 1984
Aβ40
(CSF)
CTRL-
CNC
(21)
163.56 ± 39.35
pg/mL
xMAP;
Other/Not Specified;
In-house
Aβ42
(CSF)
AD
(23)
356.2 ± 107.48
pg/mL
xMAP;
AlzBio3;
Innogenetics
McKhann et al., 1984
Aβ42
(CSF)
CTRL-
CNC
(21)
557.48 ± 88.45
pg/mL
xMAP;
AlzBio3;
Innogenetics
tau-p181
(CSF)
AD
(23)
56.37 ± 35.65
pg/mL
xMAP;
AlzBio3;
Innogenetics
McKhann et al., 1984
tau-p181
(CSF)
CTRL-
CNC
(21)
27.61 ± 7.21
pg/mL
xMAP;
AlzBio3;
Innogenetics
tau-total
(CSF)
AD
(23)
145.4 ± 89.1
pg/mL
xMAP;
AlzBio3;
Innogenetics
McKhann et al., 1984
tau-total
(CSF)
CTRL-
CNC
(21)
54.72 ± 20.13
pg/mL
xMAP;
AlzBio3;
Innogenetics

Recommends

Please login to recommend the paper.

Comments

No Available Comments

Make a Comment

To make a comment you must login or register.